|
|
Volumn 86, Issue 1, 2009, Pages 12-14
|
|
Chutes and ladders on the critical path:comparative effectiveness, product value, and the use of biomarkers in drug development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
BORTEZOMIB;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PANITUMUMAB;
CLINICAL PRACTICE;
COLORECTAL CANCER;
DRUG DEVELOPMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH PROGRAM;
HUMAN;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
ANIMALS;
BIOLOGICAL MARKERS;
CRITICAL PATHWAYS;
DRUG DESIGN;
DRUG DISCOVERY;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 67650639088
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2009.33 Document Type: Short Survey |
|
Times cited : (30)
|
|
References (0)
|
